We are live on ! Find out more
GPCR icon

Structure Therapeutics
GPCR

84 hedge funds and large institutions have $1.64B invested in Structure Therapeutics in 2023 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 29 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 6

383% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 6

175% more funds holding in top 10

Funds holding in top 10: 4 → 11 (+7)

135% more capital invested

Capital invested by funds: $699M → $1.64B (+$944M)

75% more funds holding

Funds holding: 48 → 84 (+36)

14.1% more ownership

Funds ownership: 16.43% → 30.53% (+14%)

Holders
84
Holders Change
+36
Holders Change %
+75%
% of All Funds
1.33%
Holding in Top 10
11
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+175%
% of All Funds
0.17%
New
42
Increased
29
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$64.9M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$51.8M
3
DCM
Driehaus Capital Management
Illinois
+$40.4M
4
TCM
TCG Crossover Management
California
+$37.1M
5
HH
HSG Holding
Hong Kong
+$34.3M

Top Sellers

Rank Fund Capital Flow
1
MIM
Monashee Investment Management
Massachusetts
-$23.8M
2
DTC
Deep Track Capital
Connecticut
-$23.6M
3
OCA
Octagon Capital Advisors
New York
-$3.12M
4
NCM
Nantahala Capital Management
Connecticut
-$2.08M
5
Renaissance Technologies
Renaissance Technologies
New York
-$1.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
CUAMC
76
China Universal Asset Management Company
China
$71.1K -$833K -25,857 -95%
TRCT
77
Tower Research Capital (TRC)
New York
$46.4K +$27.5K +854 +1,275%
NSIM
78
North Star Investment Management
Illinois
$44.4K +$28.4K +880 New
Osaic Holdings
79
Osaic Holdings
Arizona
$28K +$17.9K +556 New
Citigroup
80
Citigroup
New York
$6.3K +$4.03K +125 New
S
81
SignatureFD
Georgia
$5.04K – – –
Royal Bank of Canada
82
Royal Bank of Canada
Ontario, Canada
$5K +$3.32K +103 New
CA
83
Clearstead Advisors
Ohio
$3.53K +$2.26K +70 New
TFA
84
Toth Financial Advisory
Virginia
$2.52K +$1.61K +50 New
OCA
85
Octagon Capital Advisors
New York
– -$3.12M -75,000 Closed
NCM
86
Nantahala Capital Management
Connecticut
– -$2.08M -50,000 Closed
Renaissance Technologies
87
Renaissance Technologies
New York
– -$1.37M -32,900 Closed
LCM
88
Lynx1 Capital Management
Puerto Rico
– -$956K -23,000 Closed
PAM
89
Pinpoint Asset Management
Hong Kong
– -$37 -900 Closed
UBS Group
90
UBS Group
Switzerland
– -$83 -2 Closed
1 2 3
4

GPCR Hedge Fund Activity: Q3 2023 in Review

84 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Structure Therapeutics (GPCR) for Q3 2023, worth a combined $1.64B — up 135% from $699M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new GPCR positions and 6 closed out — a net gain of 36 holders — while 29 added to existing stakes and 6 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $64.9M. The largest seller was Monashee Investment Management, cutting an estimated $23.8M.

  • 84 institutional investors held Structure Therapeutics (GPCR) as of Q3 2023, up from 48 in Q2 2023.
  • Funds reported $1.64B of Structure Therapeutics stock for Q3 2023, up 135% quarter-over-quarter.
  • 42 funds opened new Structure Therapeutics positions in Q3 2023 and 6 closed out, a net change of +36 holders.
  • The largest Structure Therapeutics buyer in Q3 2023 was Janus Henderson Group, an estimated $64.9M added.
  • The largest Structure Therapeutics seller in Q3 2023 was Monashee Investment Management, an estimated $23.8M sold.

Based on aggregated 13F filings for Q3 2023.